Blocking the effects of TGF-β with an orally administered small molecule inhibitor in a mouse tumor model led to the accumulation of neutrophils with a cytotoxic and anti-tumor phenotype compared to those in control mice (44). Here, TGFB1 is linked to neoplasm.